|
|
|
National Stock Number:
6505-01-204-5298
Federal Supply Class:
6505
National Item Identification Number:
012045298
Description:
NAPROXEN TABLETS
|
Manufacturer Information:
| 00004631401 | 66002 | ROCHE LABORATORIES INC. | | 00903014801 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. | | 00904559060 | 0SYT3 | MAJOR PHARMACEUTICALS INC | | NDC00004-6314-01 | 66002 | ROCHE LABORATORIES INC. | | NDC00781-1164-13 | 59043 | GENEVA PHARMACEUTICALS INC | | NDC00903-0148-01 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. | | NDC00904-5590-60 | 0SYT3 | MAJOR PHARMACEUTICALS INC | | NDC18393-0273-53 | 26282 | SYNTEX LABORATORIES INC | | NDC51079-0794-20 | 65751 | MYLAN INSTITUTIONAL INC | | NDC67253-0621-10 | 373U9 | DAVA PHARMACEUTICALS, INC. |
|
Techincal Specification:
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 375.000 MILLIGRAMS NAPROXEN ACTIVE INGREDIENT | | FEATURES PROVIDED | UNIT DOSE | | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA | | PART NAME ASSIGNED BY CONTROLLING AGENCY | NAPROXEN TABLETS USP 375MG 100S PG | | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS | | PRIMARY CONTAINER TYPE | STRIP |
|